4//SEC Filing
Oxford Immunotec Global PLC 4
Accession 0001437749-17-003886
CIK 0001586049operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:00 PM ET
Size
6.6 KB
Accession
0001437749-17-003886
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2017-02-24+8,551→ 52,893 total - Award
Stock Option (Right to Buy)
2017-02-24+38,838→ 38,838 totalExercise: $13.50Exp: 2027-02-24→ Ordinary Shares (38,838 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2018 through January 1, 2021.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001586049
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:00 PM ET
- Size
- 6.6 KB